A 17-cm gauge radiofrequency electrode with 2–3 cm active tip and an internal cooling system attached to the radiofrequency generators were used. In some cases, multiple RF electrodes with switch control were utilized. Either artificial ascites or pleural effusion was done prior to RFA for tumors in high-risk locations. After application of aseptic technique, 10 ml of 1% lidocaine was injected through the skin. The RF electrodes were inserted percutaneously into the target tumor under real-time US with RVS guidance. All RFAs were done under conscious sedation with the use of Midazolam and Fentanyl. The vital signs and oxygen saturation were monitored during the procedure. Patients were discharged less than 48 hours after post-RFA ultrasound evaluation.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.